Case Report: Heparin-induced thrombocytopenia in a patient with COVID-19 [version 2; peer review: 2 approved]
With the spread of the novel coronavirus disease of 2019 (COVID-19) worldwide and associated high incidence of thromboembolic complications, the use of heparin is on the rise. It therefore is crucial to identify patients with contraindications for heparin. Heparin-induced thrombocytopenia (HIT) is a...
Main Authors: | Ragia Aly, Sachin Gupta, Sorab Gupta, Balraj Singh, Abhinav Goyal, Sheila Kalathil |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2021-06-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-704/v2 |
Similar Items
-
The use of direct acting oral anticoagulants in patients with COVID-19 infection
by: Ragia Aly, et al.
Published: (2021-03-01) -
Case Report: IgG multiple myeloma and chronic myeloid leukemia in a single patient [version 2; peer review: 2 approved]
by: Neeraja Swaminathan, et al.
Published: (2020-09-01) -
Case Report: Concomitant coronary stent and femoral artery thrombosis in the setting of heparin-induced thrombocytopenia [version 1; peer review: 2 approved]
by: Mejdi Ben Messaoud, et al.
Published: (2019-05-01) -
Case Report: Heparin-induced thrombocytopenia during COVID-19 outbreak: the importance of scoring system in differentiating with sepsis-induced coagulopathy [version 2; peer review: 2 approved]
by: Louisa Fadjri Kusuma Wardhani, et al.
Published: (2021-08-01) -
Heparin induced thrombocytopenia-type 2
by: Majeed Tanveer
Published: (2010-01-01)